Stock listing
NYSE:ANVS Annovis Bio, Inc. Stock
Home listing (NYSE) of Annovis Bio, Inc.
Follow Annovis Bio, Inc. into a list and get an email when it puts out news.
Share price · NYSE:ANVS
$0.978 USD +0.018 (+1.9%)
Close on Oct 20, 2026
- Day range
- $0.960 – $1.040 USDOct 20, 2026
- Volume
- 703,966 sharesOct 20, 2026
- Market cap
- $41.90M USDAt the close on Oct 20, 2026 · price × 42.83M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:ANVS · Home | $0.978 USD | +0.018 (+1.9%) | 703,966 | $0.960 | $1.040 | $0.960 | $0.960 | Close on Oct 20, 2026 |
| Frankfurt:07X | €0.858 EUR | -0.020 (-2.3%) | — | €0.858 | €0.858 | €0.858 | €0.878 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NYSE:ANVS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.978 | +0.018 | +1.9% | $0.960 | $1.040 | $0.960 | 703,966 | |
| $0.960 | -0.033 | -3.4% | $0.995 | $1.040 | $0.950 | 641,347 | |
| $0.993 | -0.057 | -5.4% | $1.060 | $1.080 | $0.987 | 641,422 | |
| $1.050 | +0.030 | +2.9% | $1.040 | $1.075 | $1.010 | 571,813 | |
| $1.020 | -0.040 | -3.8% | $1.050 | $1.080 | $1.010 | 843,701 | |
| $1.060 | -0.090 | -7.8% | $1.150 | $1.150 | $1.050 | 842,713 | |
| $1.150 | -0.060 | -5.0% | $1.210 | $1.210 | $1.140 | 460,230 | |
| $1.210 | +0.040 | +3.4% | $1.170 | $1.240 | $1.140 | 521,897 | |
| $1.170 | -0.040 | -3.3% | $1.210 | $1.210 | $1.140 | 815,379 | |
| $1.210 | +0.030 | +2.5% | $1.170 | $1.230 | $1.160 | 430,012 | |
| $1.180 | -0.020 | -1.7% | $1.200 | $1.240 | $1.170 | 538,700 | |
| $1.200 | +0.020 | +1.7% | $1.160 | $1.200 | $1.140 | 657,600 | |
| $1.180 | +0.010 | +0.9% | $1.190 | $1.200 | $1.140 | 648,500 | |
| $1.170 | -0.100 | -7.9% | $1.270 | $1.280 | $1.160 | 1,201,800 | |
| $1.270 | -0.030 | -2.3% | $1.300 | $1.340 | $1.270 | 572,500 | |
| $1.300 | -0.080 | -5.8% | $1.390 | $1.410 | $1.300 | 812,000 | |
| $1.380 | +0.070 | +5.3% | $1.320 | $1.430 | $1.300 | 1,190,000 | |
| $1.310 | -0.020 | -1.5% | $1.350 | $1.360 | $1.310 | 573,500 | |
| $1.330 | +0.060 | +4.7% | $1.270 | $1.340 | $1.230 | 853,900 | |
| $1.270 | +0.010 | +0.8% | $1.300 | $1.330 | $1.240 | 1,144,300 | |
| $1.260 | +0.070 | +5.9% | $1.190 | $1.300 | $1.190 | 1,214,700 | |
| $1.190 | +0.050 | +4.4% | $1.160 | $1.220 | $1.160 | 882,300 | |
| $1.140 | +0.040 | +3.6% | $1.120 | $1.160 | $1.090 | 677,900 | |
| $1.100 | +0.060 | +5.8% | $1.100 | $1.170 | $1.080 | 1,521,800 | |
| $1.040 | -0.080 | -7.1% | $1.120 | $1.130 | $1.040 | 1,431,100 | |
| $1.120 | -0.020 | -1.8% | $1.140 | $1.140 | $1.100 | 823,200 | |
| $1.140 | +0.020 | +1.8% | $1.100 | $1.170 | $1.100 | 1,201,700 | |
| $1.120 | -0.070 | -5.9% | $1.200 | $1.230 | $1.100 | 1,893,400 | |
| $1.190 | -0.030 | -2.5% | $1.210 | $1.260 | $1.170 | 1,337,500 | |
| $1.220 | -0.080 | -6.2% | $1.310 | $1.320 | $1.220 | 1,743,600 | |
| $1.300 | -0.090 | -6.5% | $1.390 | $1.400 | $1.300 | 1,962,800 | |
| $1.390 | +0.010 | +0.7% | $1.400 | $1.440 | $1.380 | 1,532,600 | |
| $1.380 | -0.320 | -18.8% | $1.650 | $1.680 | $1.320 | 7,332,100 | |
| $1.700 | +0.010 | +0.6% | $1.710 | $1.760 | $1.690 | 606,800 | |
| $1.690 | -0.030 | -1.7% | $1.730 | $1.730 | $1.670 | 457,200 | |
| $1.720 | 0.000 | 0.0% | $1.720 | $1.780 | $1.700 | 425,500 | |
| $1.720 | -0.090 | -5.0% | $1.780 | $1.830 | $1.710 | 498,400 | |
| $1.810 | +0.030 | +1.7% | $1.760 | $1.810 | $1.760 | 292,300 | |
| $1.780 | -0.040 | -2.2% | $1.840 | $1.860 | $1.760 | 233,600 | |
| $1.820 | +0.070 | +4.0% | $1.760 | $1.825 | $1.760 | 560,283 | |
| $1.750 | -0.070 | -3.8% | $1.830 | $1.830 | $1.740 | 670,723 | |
| $1.820 | +0.030 | +1.7% | $1.780 | $1.840 | $1.770 | 618,600 | |
| $1.790 | -0.060 | -3.2% | $1.840 | $1.890 | $1.780 | 548,800 | |
| $1.850 | +0.050 | +2.8% | $1.900 | $1.900 | $1.790 | 746,800 | |
| $1.800 | +0.060 | +3.4% | $1.750 | $1.820 | $1.740 | 449,500 | |
| $1.740 | -0.110 | -5.9% | $1.820 | $1.850 | $1.740 | 662,000 | |
| $1.850 | +0.060 | +3.4% | $1.830 | $1.900 | $1.800 | 949,700 | |
| $1.790 | -0.010 | -0.6% | $1.840 | $1.860 | $1.750 | 712,000 | |
| $1.800 | -0.090 | -4.8% | $1.870 | $1.900 | $1.800 | 502,300 | |
| $1.890 | 0.000 | 0.0% | $1.910 | $1.910 | $1.860 | 351,700 | |
| $1.890 | +0.010 | +0.5% | $1.900 | $1.900 | $1.850 | 321,100 | |
| $1.880 | +0.020 | +1.1% | $1.900 | $1.950 | $1.850 | 557,300 | |
| $1.860 | -0.010 | -0.5% | $1.910 | $1.910 | $1.810 | 317,200 | |
| $1.870 | 0.000 | 0.0% | $1.900 | $1.980 | $1.860 | 1,100,300 | |
| $1.870 | +0.150 | +8.7% | $1.750 | $1.910 | $1.720 | 809,000 | |
| $1.720 | -0.030 | -1.7% | $1.780 | $1.820 | $1.710 | 460,100 | |
| $1.750 | -0.020 | -1.1% | $1.810 | $1.810 | $1.700 | 353,000 | |
| $1.770 | +0.070 | +4.1% | $1.720 | $1.790 | $1.720 | 388,500 | |
| $1.700 | +0.010 | +0.6% | $1.670 | $1.760 | $1.670 | 567,900 | |
| $1.690 | +0.020 | +1.2% | $1.670 | $1.700 | $1.550 | 718,800 | |
| $1.670 | +0.010 | +0.6% | $1.690 | $1.720 | $1.630 | 497,200 | |
| $1.660 | -0.090 | -5.1% | $1.740 | $1.760 | $1.640 | 1,034,200 | |
| $1.750 | +0.010 | +0.6% | $1.700 | $1.760 | $1.690 | 630,700 | |
| $1.740 | -0.010 | -0.6% | $1.720 | $1.770 | $1.720 | 317,400 | |
| $1.750 | +0.060 | +3.6% | $1.720 | $1.770 | $1.690 | 364,400 | |
| $1.690 | -0.050 | -2.9% | $1.700 | $1.740 | $1.660 | 620,100 |
- Ticker
- NYSE:ANVS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Sep 24, 2026
Annovis Bio Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's disease
Latest deck · Jan 28, 2026
Corporate Update (January 2026)
Corporate update · 26 slides
Latest news
Annovis Bio Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's disease
Sep 24, 2026
Closed $1.33 (+4.7%) on Sep 24, 2026
Annovis to Host Corporate Update Webinar on September 2, 2026
Aug 25, 2026
Closed $1.82 (+4.0%) on Aug 25, 2026
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
Aug 14, 2026
Closed $1.85 (+3.4%) on Aug 14, 2026
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
Jul 7, 2026
Closed $1.92 (-2.5%) on Jul 7, 2026
Decks
Corporate Update (January 2026)
Corporate update · 26 slides · Jan 28, 2026
Corporate Update (December 2024)
Corporate update · 23 slides · Dec 11, 2024
Corporate Update (June 2024)
Corporate update · 15 slides · Jun 11, 2024
Investor Presentation (February 2023)
Investor deck · 28 slides · Feb 13, 2023
Annovis Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 48 in all · newest Sep 24, 2026 · oldest 2025
- Decks
- 11 decks · latest Jan 28, 2026
Where Annovis Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:ANVS · Home listing · This page | NYSE | United States | USD |
| LS Exchange:A2PNH2 | LS Exchange | Germany | EUR |
| gettex:07X | gettex | Germany | EUR |
| Lang & Schwarz:A2PNH2 | Lang & Schwarz | Germany | EUR |
| BOATS:ANVS | BOATS | United States | USD |
| Dusseldorf:07X | Dusseldorf | Germany | EUR |
| Frankfurt:07X | Frankfurt | Germany | EUR |
| Munich:07X | Munich | Germany | EUR |
| Stuttgart:07X | Stuttgart | Germany | EUR |
| Tradegate:07X | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Annovis Bio, Inc.